Skip to main content
Erschienen in: Breast Cancer 4/2016

21.04.2015 | Original Article

Mitochondrial complex I and V gene polymorphisms associated with breast cancer in mizo-mongloid population

verfasst von: Sunaina Thapa, Freda Lalrohlui, Souvik Ghatak, John Zohmingthanga, Doris Lallawmzuali, Jeremy L. Pautu, Nachimuthu Senthil Kumar

Erschienen in: Breast Cancer | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Mizoram has the highest incidence of cancer in India. Among women, breast cancer is most prevalent and the state occupies fifth position globally. The reason for high rate of cancer in this region is still not known but it may be related to ethnic/racial variations or lifestyle factors.

Methods

The present study aims to identify the candidate mitochondrial DNA (mtDNA) biomarkers—ND1and ATPase for early breast cancer diagnosis in Mizo population. Genomic DNA was extracted from blood samples of 30 unrelated breast cancer and ten healthy women. The mtNDI and mtATP coding regions were amplified by step-down PCR and were subjected to restriction enzyme digestion and direct sequencing by Sanger method. Subsequently, the results of the DNA sequence analysis were compared with that of the revised Cambridge Reference Sequence (rCRS) using Mutation Surveyor and MITOMAP.

Results

Most of the mutations were reported and new mutations that are not reported in relationship with breast cancer were also found. The mutations are mostly base substitutions. The effect of non-synonymous substitutions on the amino acid sequence was determined using the PolyPhen-2 software. Statistical analysis was performed for both cases and controls. Odds ratios (ORs) and 95 % confidence intervals (CIs) were estimated from logistic regression. High intake of animal fat and age at menarche was found to be associated with a higher risk of breast cancer in Mizo population.

Conclusion

Our results also showed that ATPase6 as compared to ATPase8 gene is far more predisposed to variations in Mizo population with breast cancer and this finding may play an important role in breast cancer prognosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Phukan RK, Zomawia E, Hazarika NC, Baruah D, Mahanta J. High prevalence of stomach cancer among the people of Mizoram, India. Curr Sci. 2004;87:3. Phukan RK, Zomawia E, Hazarika NC, Baruah D, Mahanta J. High prevalence of stomach cancer among the people of Mizoram, India. Curr Sci. 2004;87:3.
2.
Zurück zum Zitat Perou CM, Sorlie T, Eisen MB, Van De Rijn M, Jeffrey SS. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.CrossRefPubMed Perou CM, Sorlie T, Eisen MB, Van De Rijn M, Jeffrey SS. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.CrossRefPubMed
3.
Zurück zum Zitat Man Yu, Yurong S, Fei Z, Yunli Z, Yi Y, Xiyin W, Lin Z, Ruifang N. Sequence variations of mitochondrial DNA D-loop region are highly frequent events in familial breast cancer. J Biomed Sci. 2008;15(4):535–43.CrossRef Man Yu, Yurong S, Fei Z, Yunli Z, Yi Y, Xiyin W, Lin Z, Ruifang N. Sequence variations of mitochondrial DNA D-loop region are highly frequent events in familial breast cancer. J Biomed Sci. 2008;15(4):535–43.CrossRef
4.
Zurück zum Zitat Yeole BB, Kurkure AP. An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades. Asian Pac J Cancer Prev. 2003;4:51–6.PubMed Yeole BB, Kurkure AP. An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades. Asian Pac J Cancer Prev. 2003;4:51–6.PubMed
5.
Zurück zum Zitat Yip CH, Taib NA, Mohamed I. Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev. 2006;7:369–74.PubMed Yip CH, Taib NA, Mohamed I. Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev. 2006;7:369–74.PubMed
6.
Zurück zum Zitat Saxena S, Kaushal M, Sharma J, Zomawia E, Kapur S. Genomic alterations in breast cancer patients from Northeast India using 10 K SNP arrays. Genome Biol. 2010;11:34.CrossRef Saxena S, Kaushal M, Sharma J, Zomawia E, Kapur S. Genomic alterations in breast cancer patients from Northeast India using 10 K SNP arrays. Genome Biol. 2010;11:34.CrossRef
7.
Zurück zum Zitat Datta K, Biswas J. Influence of dietary habits, physical activity and affluence factors on breast cancer in East India—a case-control study. Asian Pac J Cancer Prev. 2009;10:219–22.PubMed Datta K, Biswas J. Influence of dietary habits, physical activity and affluence factors on breast cancer in East India—a case-control study. Asian Pac J Cancer Prev. 2009;10:219–22.PubMed
8.
Zurück zum Zitat Cann RL, Stokening M, Wilson AC. Mitochondrial DNA and human evolution. Nature. 1987;325:32–6.CrossRef Cann RL, Stokening M, Wilson AC. Mitochondrial DNA and human evolution. Nature. 1987;325:32–6.CrossRef
9.
Zurück zum Zitat Anderson S, Bankier AT, Barrell BG, Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–65.CrossRefPubMed Anderson S, Bankier AT, Barrell BG, Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–65.CrossRefPubMed
10.
Zurück zum Zitat Czarnecka AM, Golik P, Bartnik E. Mitochondrial DNA mutations in human neoplasia. J Appl Genet. 2006;47:67–78.CrossRefPubMed Czarnecka AM, Golik P, Bartnik E. Mitochondrial DNA mutations in human neoplasia. J Appl Genet. 2006;47:67–78.CrossRefPubMed
11.
Zurück zum Zitat Czarnecka AM, Marino Gammazza A, Di Felice V, Zummo G, Cappello F. Cancer as a ‘Mitochondriopathy’. J Cancer Mol. 2007;3:71–9. Czarnecka AM, Marino Gammazza A, Di Felice V, Zummo G, Cappello F. Cancer as a ‘Mitochondriopathy’. J Cancer Mol. 2007;3:71–9.
12.
Zurück zum Zitat Czarnecka AM, Krawczyk T, Czarnecki JS, et al. Methodology for mitochondrial DNA research in oncology: goals and pitfalls. ARS Medica Tomitana. 2008;14:48–64. Czarnecka AM, Krawczyk T, Czarnecki JS, et al. Methodology for mitochondrial DNA research in oncology: goals and pitfalls. ARS Medica Tomitana. 2008;14:48–64.
13.
Zurück zum Zitat Carew JS, Huang P. Mitochondrial defects in cancer. Molecular Cancer. 2002;1:1–12.CrossRef Carew JS, Huang P. Mitochondrial defects in cancer. Molecular Cancer. 2002;1:1–12.CrossRef
14.
Zurück zum Zitat Jonckheere ISJAM, Rodenburg RJT. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis. 2012;35:221–5.CrossRef Jonckheere ISJAM, Rodenburg RJT. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis. 2012;35:221–5.CrossRef
15.
Zurück zum Zitat Ghatak S, Muthukumaran RB, Nachimuthu SK. A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis. J Biomol Tech. 2013;24(4):224–31.PubMedPubMedCentral Ghatak S, Muthukumaran RB, Nachimuthu SK. A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis. J Biomol Tech. 2013;24(4):224–31.PubMedPubMedCentral
16.
Zurück zum Zitat Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15:617–31.CrossRefPubMed Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15:617–31.CrossRefPubMed
17.
Zurück zum Zitat Carroll KK, Braden LM. Dietary fat and mammary carcinogenesis. Nutr Cancer. 1985;6:254–9.CrossRef Carroll KK, Braden LM. Dietary fat and mammary carcinogenesis. Nutr Cancer. 1985;6:254–9.CrossRef
18.
Zurück zum Zitat Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer. 1986;58:2363–71.CrossRefPubMed Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer. 1986;58:2363–71.CrossRefPubMed
19.
Zurück zum Zitat Hirayama T. Epidemiology of breast cancer with special reference to the role of diet. Prev Med. 1978;7:173–95.CrossRefPubMed Hirayama T. Epidemiology of breast cancer with special reference to the role of diet. Prev Med. 1978;7:173–95.CrossRefPubMed
20.
Zurück zum Zitat Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsouyanni K, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990;82:561–9.CrossRefPubMed Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsouyanni K, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990;82:561–9.CrossRefPubMed
21.
Zurück zum Zitat Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15:617–31.CrossRefPubMed Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15:617–31.CrossRefPubMed
22.
Zurück zum Zitat Boyd NF, Martin LJ, Noffel M, Lockwood GA, Tritchler DL. A meta analysis of studies of dietary fat and breast cancer risk. Br J Cancer. 1993;68:627–36.CrossRefPubMedPubMedCentral Boyd NF, Martin LJ, Noffel M, Lockwood GA, Tritchler DL. A meta analysis of studies of dietary fat and breast cancer risk. Br J Cancer. 1993;68:627–36.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Hunter DJ, Spiegelman D, Adami HO, Beeson L, van den Brandt PA, Folsom AR, et al. Cohort studies of fat intake and the risk of breast cancer—a pooled analysis. N Engl J Med. 1996;334:356–61.CrossRefPubMed Hunter DJ, Spiegelman D, Adami HO, Beeson L, van den Brandt PA, Folsom AR, et al. Cohort studies of fat intake and the risk of breast cancer—a pooled analysis. N Engl J Med. 1996;334:356–61.CrossRefPubMed
24.
Zurück zum Zitat Ghatak S, Doris L, Mawia L, Ricky S, Zothanpuia, Jeremy LP, Muthukumaran RB, Nachimuthu SK. Mitochondrial D-Loop and cytochrome oxidase subunit I polymorphisms among the breast cancer patients of Mizoram, Northeast India. Curr Genet. 2014;60:201–12.CrossRefPubMed Ghatak S, Doris L, Mawia L, Ricky S, Zothanpuia, Jeremy LP, Muthukumaran RB, Nachimuthu SK. Mitochondrial D-Loop and cytochrome oxidase subunit I polymorphisms among the breast cancer patients of Mizoram, Northeast India. Curr Genet. 2014;60:201–12.CrossRefPubMed
25.
Zurück zum Zitat Ghatak Lallawmzuali D, Mukherjee S, Mawia L, Pautu JL, Nachimuthu SK. Polymorphism in mtDNA control region of mizo-mongloid breast cancer samples as revealed by PCR-RFLP analysis. Mitochondrial DNA. 2014. doi:10.3109/19401736.2014.982627.PubMed Ghatak Lallawmzuali D, Mukherjee S, Mawia L, Pautu JL, Nachimuthu SK. Polymorphism in mtDNA control region of mizo-mongloid breast cancer samples as revealed by PCR-RFLP analysis. Mitochondrial DNA. 2014. doi:10.​3109/​19401736.​2014.​982627.PubMed
26.
Zurück zum Zitat Massoud G, Reza M, Forouzandeh F, Behnam K, Nasrin M, Massoud H. The mitochondrial ATPase6 gene is more susceptible to mutation than the ATPase8 gene in breast cancer patients. Cancer cell international. 2014;14:21.CrossRef Massoud G, Reza M, Forouzandeh F, Behnam K, Nasrin M, Massoud H. The mitochondrial ATPase6 gene is more susceptible to mutation than the ATPase8 gene in breast cancer patients. Cancer cell international. 2014;14:21.CrossRef
27.
Zurück zum Zitat Shidara YYK, Kanamori T, Nakano K, Kwong JQ, Manfredi G, Oda H, Ohta S. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 2005;65(5):1655–63.CrossRefPubMed Shidara YYK, Kanamori T, Nakano K, Kwong JQ, Manfredi G, Oda H, Ohta S. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 2005;65(5):1655–63.CrossRefPubMed
29.
Zurück zum Zitat Tan DJBR, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002;62(4):972–6.PubMed Tan DJBR, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002;62(4):972–6.PubMed
30.
Zurück zum Zitat Czarnecka AMKA, Krawczyk T, Zdrozny M, Arnold RS, Bartnik E, Petros JA. Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncol Rep. 2010;23(2):531–5.PubMed Czarnecka AMKA, Krawczyk T, Zdrozny M, Arnold RS, Bartnik E, Petros JA. Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncol Rep. 2010;23(2):531–5.PubMed
31.
Zurück zum Zitat Aikhionbare FOKM, Carey D, Okoli J, Go R. Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? Mol Cancer. 2004;3:30.CrossRefPubMedPubMedCentral Aikhionbare FOKM, Carey D, Okoli J, Go R. Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? Mol Cancer. 2004;3:30.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Aikhionbare FOMS, Kumaresan K, Zavareh M, Olatinwo M, Odunsi K, Partridge E. Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J Carcinog. 2007;6:1.CrossRefPubMedPubMedCentral Aikhionbare FOMS, Kumaresan K, Zavareh M, Olatinwo M, Odunsi K, Partridge E. Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J Carcinog. 2007;6:1.CrossRefPubMedPubMedCentral
33.
34.
Zurück zum Zitat Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989;123(3):585–95.PubMedPubMedCentral Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989;123(3):585–95.PubMedPubMedCentral
Metadaten
Titel
Mitochondrial complex I and V gene polymorphisms associated with breast cancer in mizo-mongloid population
verfasst von
Sunaina Thapa
Freda Lalrohlui
Souvik Ghatak
John Zohmingthanga
Doris Lallawmzuali
Jeremy L. Pautu
Nachimuthu Senthil Kumar
Publikationsdatum
21.04.2015
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 4/2016
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-015-0611-1

Weitere Artikel der Ausgabe 4/2016

Breast Cancer 4/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.